P4O2 ILD Extension — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

P4O2 ILD Extension — Stella

Home/Interstitial Lung Disease/

View on ClinicalTrials.gov

Recruiting

Back to Interstitial Lung Disease trials

Trial locations(1 site)

Netherlands

Amsterdam UMC, locatie VUmc, Amsterdam, North Holland

Key details

Sponsor

Amsterdam UMC, location VUmc

Collaborators

AbbVie, Boehringer Ingelheim

Enrollment target

~450 participants

Started

November 2024

Primary completion

October 2028

Age range

18 Years – 80 Years

Last updated April 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.